Literature DB >> 22311151

RapidArc combined with the active breathing coordinator provides an effective and accurate approach for the radiotherapy of hepatocellular carcinoma.

G Z Gong1, Y Yin, L G Xing, Y J Guo, T Liu, J Chen, J Lu, C Ma, T Sun, T Bai, G Zhang, R Wang.   

Abstract

PURPOSE: The goal of this research was to investigate the feasibility of volumetric modulated arc therapy, RapidArc (RA), in association with the active breathing coordinator (ABC) for the treatment of hepatocellular carcinoma (HCC) with radiotherapy. PATIENTS AND MATERIALS: A total of 12 patients with HCC, after receiving transcatheter arterial chemoembolization (TACE) treatment, underwent three-dimensional computer tomography (3D-CT) scanning associated with ABC using end inspiration hold (EIH), end expiration hold (EEH), and free breathing (FB) techniques. The three-dimensional conformal radiotherapy (3D-CRT), intensity-modulated radiotherapy (IMRT), and RA plans (three 135° arcs) were designed on different CT images, respectively. The liver volume, gross tumor volume (GTV), and planning target volume (PTV) of the three breath status and the dosimetric differences of the different plans were compared.
RESULTS: There were no significant differences in the volumes of live and GTV between the three breathing techniques (p > 0.05); the PTV in FB was greater than in the EEH and EIH (p < 0.05). The overall conformality index (CI) and homogeneity index (HI) for RA (CI 0.92, HI 0.90) were better than IMRT (CI 0.90, HI 0.89) and 3D-CRT (CI 0.70, HI 0.84) for the three breathing techniques (p< 0.05). The RA and IMRT significantly reduced the mean dose, V(20), V(30), and V(40) of normal liver compared to 3D-CRT, while the V(5) and V(10) in RA were higher than in IMRT. The mean values in mean dose, V(10), V(20), V(30), and V(40) of the normal liver were reduced from 13.12 Gy, 46%, 24%, 13%, and 8% in RA(FB) to 10.23 Gy, 35%, 16%, 8%, and 5% in RA(EEH) and 9.23 Gy, 32%, 16%, 8%, and 5% in RA(EIH ), respectively. In addition, the treatment time of RA was equal to 3D-CRT, which was significantly shorter than IMRT.
CONCLUSION: RA in conjunction with ABC for the treatment of HCC with radiotherapy can achieve better dose delivery and ensure the accuracy of the target volume, which spares more organs at risk, uses fewer monitor units, and shortens treatment time.

Entities:  

Mesh:

Year:  2012        PMID: 22311151     DOI: 10.1007/s00066-011-0044-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  42 in total

1.  Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer.

Authors:  Matthias Guckenberger; Sami Ok; Bülent Polat; Reinhart A Sweeney; Michael Flentje
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

2.  Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control.

Authors:  Laura A Dawson; Cynthia Eccles; Jean-Pierre Bissonnette; Kristy K Brock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-15       Impact factor: 7.038

3.  The number of beams in IMRT--theoretical investigations and implications for single-arc IMRT.

Authors:  Thomas Bortfeld
Journal:  Phys Med Biol       Date:  2010-01-07       Impact factor: 3.609

Review 4.  Future perspectives in hepatocellular carcinoma.

Authors:  Marcus A Wörns; Peter R Galle
Journal:  Dig Liver Dis       Date:  2010-07       Impact factor: 4.088

5.  Radiotherapy for hepatocellular carcinoma.

Authors:  K Tokuuye; M Sumi; Y Kagami; S Murayama; M Kawashima; H Ikeda; H Ueno; T Okusaka; S Okada
Journal:  Strahlenther Onkol       Date:  2000-09       Impact factor: 3.621

6.  Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study.

Authors:  Zhi-Gang Ren; Jian-Dong Zhao; Ke Gu; Zhen Chen; Jun-Hua Lin; Zhi-Yong Xu; Wei-Gang Hu; Zhen-Hua Zhou; Lu-Ming Liu; Guo-Liang Jiang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-04-24       Impact factor: 7.038

7.  Potential of adaptive radiotherapy to escalate the radiation dose in combined radiochemotherapy for locally advanced non-small cell lung cancer.

Authors:  Matthias Guckenberger; Juergen Wilbert; Anne Richter; Kurt Baier; Michael Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-12       Impact factor: 7.038

8.  Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials.

Authors:  Reinhold Graf; Dirk Boehmer; Volker Budach; Peter Wust
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

9.  Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control.

Authors:  Matthias Guckenberger; Anne Richter; Juergen Wilbert; Michael Flentje; Mike Partridge
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-15       Impact factor: 7.038

10.  Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography.

Authors:  Matthias Guckenberger; Reinhart A Sweeney; Juergen Wilbert; Thomas Krieger; Anne Richter; Kurt Baier; Gerd Mueller; Otto Sauer; Michael Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-01       Impact factor: 7.038

View more
  11 in total

1.  Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma.

Authors:  Tae Hyun Kim; Joong-Won Park; Yeon-Joo Kim; Bo Hyun Kim; Sang Myung Woo; Sung Ho Moon; Sang Soo Kim; Woo Jin Lee; Dae Yong Kim; Chang-Min Kim
Journal:  Strahlenther Onkol       Date:  2014-03-18       Impact factor: 3.621

2.  Three-dimensional surface scanning for accurate patient positioning and monitoring during breast cancer radiotherapy.

Authors:  C Gaisberger; P Steininger; B Mitterlechner; S Huber; H Weichenberger; F Sedlmayer; H Deutschmann
Journal:  Strahlenther Onkol       Date:  2013-06-07       Impact factor: 3.621

3.  Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Sung Uk Lee; Joong-Won Park; Tae Hyun Kim; Yeon-Joo Kim; Sang Myung Woo; Young-Hwan Koh; Woo Jin Lee; Sang-Jae Park; Dae Yong Kim; Chang-Min Kim
Journal:  Strahlenther Onkol       Date:  2014-03-04       Impact factor: 3.621

4.  Radiotherapy with volumetric modulated arc therapy for hepatocellular carcinoma patients ineligible for surgery or ablative treatments.

Authors:  P-M Wang; W-C Hsu; N-N Chung; F-L Chang; A Fogliata; L Cozzi
Journal:  Strahlenther Onkol       Date:  2013-02-20       Impact factor: 3.621

5.  Optimization by visualization of indices.

Authors:  Uwe Haverkamp; Darius Norkus; Jan Kriz; Mariam Müller Minai; Franz-Josef Prott; Hans Theodor Eich
Journal:  Strahlenther Onkol       Date:  2014-06-28       Impact factor: 3.621

6.  Single-dose radiosurgical treatment for hepatic metastases--therapeutic outcome of 138 treated lesions from a single institution.

Authors:  Daniel Habermehl; Klaus K Herfarth; Justo Lorenzo Bermejo; Holger Hof; Stefan Rieken; Sabine Kuhn; Thomas Welzel; Jürgen Debus; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2013-07-09       Impact factor: 3.481

7.  Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.

Authors:  Daniel Habermehl; Katrin Henkner; Swantje Ecker; Oliver Jäkel; Jürgen Debus; Stephanie E Combs
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

8.  Reduced lung dose during radiotherapy for thoracic esophageal carcinoma: VMAT combined with active breathing control for moderate DIBH.

Authors:  Guanzhong Gong; Ruozheng Wang; Yujie Guo; Deyin Zhai; Tonghai Liu; Jie Lu; Jinhu Chen; Chengxin Liu; Yong Yin
Journal:  Radiat Oncol       Date:  2013-12-20       Impact factor: 3.481

9.  Study of an Oxygen Supply and Oxygen Saturation Monitoring System for Radiation Therapy Associated with the Active Breathing Coordinator.

Authors:  Guanzhong Gong; Yujie Guo; Xuemei Sun; Xiuying Wang; Yong Yin; David Dagan Feng
Journal:  Sci Rep       Date:  2018-01-19       Impact factor: 4.379

10.  Dosimetric assessment of patient-specific breath-hold reproducibility on liver motion for SBRT planning.

Authors:  Lan Lu; Zi Ouyang; Sara Lin; Anthony Mastroianni; Kevin L Stephans; Ping Xia
Journal:  J Appl Clin Med Phys       Date:  2020-04-26       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.